On Wednesday, health sector focused software company Oneview Healthcare (ASX: ONE) announced its half year results. The company beat prospectus numbers with a 493% increase in revenue on the previous corresponding period. Live beds, contracted beds and pipeline for the company were also all well above prospectus forecasts. Shares in Oneview closed up 22% for the week, and are now up 43% for the month to date. We hold Oneview as a research driven investment in WAM Capital and WAM Research.